AFS
ALNY icon

Annapolis Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Annapolis Financial Services’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10
Closed -$2K – 440
2022
Q3 		$2K Hold
10
– – ﹤0.01% 452
2022
Q2 		$1K Hold
10
– – ﹤0.01% 401
2022
Q1 		$2K Hold
10
– – ﹤0.01% 397
2021
Q4 		$2K Hold
10
– – ﹤0.01% 397
2021
Q3 		$2K Hold
10
– – ﹤0.01% 387
2021
Q2 		$2K Hold
10
– – ﹤0.01% 368
2021
Q1 		$1K Hold
10
– – ﹤0.01% 377
2020
Q4 		$1K Buy
+10
New +$1.33K ﹤0.01% 375

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Annapolis Financial Services's ALNY Position: Q4 2022 in Review

Annapolis Financial Services sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2022, closing a stake of 10 shares — an estimated $2K sold.

Annapolis Financial Services first reported a position in ALNY in Q4 2020 and held it in 8 quarters. The position peaked at $2K in Q3 2022. 487 funds tracked by Wall St. Rank hold ALNY as of Q4 2022.

  • Annapolis Financial Services reported no remaining Alnylam Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Annapolis Financial Services sold 10 Alnylam Pharmaceuticals shares in Q4 2022, an estimated $2K.
  • Annapolis Financial Services first reported a position in Alnylam Pharmaceuticals in Q4 2020 and held it in 8 quarters.
  • Annapolis Financial Services's Alnylam Pharmaceuticals position peaked at $2K in Q3 2022.
  • 487 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2022.

Based on Annapolis Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.